Global Standalone Cancer Registry Software Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Standalone Cancer Registry Software Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Public Database
1.2.3 Commercial Database
1.3 Market by Application
1.3.1 Global Standalone Cancer Registry Software Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Healthcare Providers
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Standalone Cancer Registry Software Market Size (2017-2028)
2.2 Standalone Cancer Registry Software Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Standalone Cancer Registry Software Market Size by Region (2017-2022)
2.4 Global Standalone Cancer Registry Software Market Size Forecast by Region (2023-2028)
2.5 Global Top Standalone Cancer Registry Software Countries Ranking by Market Size
3 Standalone Cancer Registry Software Competitive by Company
3.1 Global Standalone Cancer Registry Software Revenue by Players
3.1.1 Global Standalone Cancer Registry Software Revenue by Players (2017-2022)
3.1.2 Global Standalone Cancer Registry Software Market Share by Players (2017-2022)
3.2 Global Standalone Cancer Registry Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Standalone Cancer Registry Software Revenue
3.4 Global Standalone Cancer Registry Software Market Concentration Ratio
3.4.1 Global Standalone Cancer Registry Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Standalone Cancer Registry Software Revenue in 2021
3.5 Global Standalone Cancer Registry Software Key Players Head office and Area Served
3.6 Key Players Standalone Cancer Registry Software Product Solution and Service
3.7 Date of Enter into Standalone Cancer Registry Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Standalone Cancer Registry Software Breakdown Data by Type
4.1 Global Standalone Cancer Registry Software Historic Revenue by Type (2017-2022)
4.2 Global Standalone Cancer Registry Software Forecasted Revenue by Type (2023-2028)
5 Global Standalone Cancer Registry Software Breakdown Data by Application
5.1 Global Standalone Cancer Registry Software Historic Market Size by Application (2017-2022)
5.2 Global Standalone Cancer Registry Software Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Standalone Cancer Registry Software Revenue by Company (2020-2022)
6.2 North America Standalone Cancer Registry Software Revenue by Type (2017-2028)
6.3 North America Standalone Cancer Registry Software Revenue by Application (2017-2028)
6.4 North America Standalone Cancer Registry Software Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Standalone Cancer Registry Software Revenue by Company (2020-2022)
7.2 Europe Standalone Cancer Registry Software Revenue by Type (2017-2028)
7.3 Europe Standalone Cancer Registry Software Revenue by Application (2017-2028)
7.4 Europe Standalone Cancer Registry Software Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Standalone Cancer Registry Software Revenue by Company (2020-2022)
8.2 Asia Pacific Standalone Cancer Registry Software Revenue by Type (2017-2028)
8.3 Asia Pacific Standalone Cancer Registry Software Revenue by Application (2017-2028)
8.4 Asia Pacific Standalone Cancer Registry Software Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Standalone Cancer Registry Software Revenue by Company (2020-2022)
9.2 Latin America Standalone Cancer Registry Software Revenue by Type (2017-2028)
9.3 Latin America Standalone Cancer Registry Software Revenue by Application (2017-2028)
9.4 Latin America Standalone Cancer Registry Software Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Standalone Cancer Registry Software Revenue by Company (2020-2022)
10.2 Middle East and Africa Standalone Cancer Registry Software Revenue by Type (2017-2028)
10.3 Middle East and Africa Standalone Cancer Registry Software Revenue by Application (2017-2028)
10.4 Middle East and Africa Standalone Cancer Registry Software Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 McKesson Corporation
11.1.1 McKesson Corporation Company Details
11.1.2 McKesson Corporation Business Overview
11.1.3 McKesson Corporation Standalone Cancer Registry Software Products and Services
11.1.4 McKesson Corporation Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022)
11.1.5 McKesson Corporation Standalone Cancer Registry Software SWOT Analysis
11.1.6 McKesson Corporation Recent Developments
11.2 Elekta
11.2.1 Elekta Company Details
11.2.2 Elekta Business Overview
11.2.3 Elekta Standalone Cancer Registry Software Products and Services
11.2.4 Elekta Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022)
11.2.5 Elekta Standalone Cancer Registry Software SWOT Analysis
11.2.6 Elekta Recent Developments
11.3 C/NET Solutions
11.3.1 C/NET Solutions Company Details
11.3.2 C/NET Solutions Business Overview
11.3.3 C/NET Solutions Standalone Cancer Registry Software Products and Services
11.3.4 C/NET Solutions Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022)
11.3.5 C/NET Solutions Standalone Cancer Registry Software SWOT Analysis
11.3.6 C/NET Solutions Recent Developments
11.4 Electronic Registry Systems
11.4.1 Electronic Registry Systems Company Details
11.4.2 Electronic Registry Systems Business Overview
11.4.3 Electronic Registry Systems Standalone Cancer Registry Software Products and Services
11.4.4 Electronic Registry Systems Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022)
11.4.5 Electronic Registry Systems Standalone Cancer Registry Software SWOT Analysis
11.4.6 Electronic Registry Systems Recent Developments
11.5 Rocky Mountain Cancer Data Systems
11.5.1 Rocky Mountain Cancer Data Systems Company Details
11.5.2 Rocky Mountain Cancer Data Systems Business Overview
11.5.3 Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Products and Services
11.5.4 Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022)
11.5.5 Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software SWOT Analysis
11.5.6 Rocky Mountain Cancer Data Systems Recent Developments
11.6 Onco
11.6.1 Onco Company Details
11.6.2 Onco Business Overview
11.6.3 Onco Standalone Cancer Registry Software Products and Services
11.6.4 Onco Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022)
11.6.5 Onco Standalone Cancer Registry Software SWOT Analysis
11.6.6 Onco Recent Developments
12 Standalone Cancer Registry Software Market Dynamics
12.1 Standalone Cancer Registry Software Market Trends
12.2 Standalone Cancer Registry Software Market Drivers
12.3 Standalone Cancer Registry Software Market Challenges
12.4 Standalone Cancer Registry Software Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Standalone Cancer Registry Software Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Public Database
Table 3. Key Players of Commercial Database
Table 4. Global Standalone Cancer Registry Software Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Standalone Cancer Registry Software Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Standalone Cancer Registry Software Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Standalone Cancer Registry Software Revenue Market Share by Region (2017-2022)
Table 8. Global Standalone Cancer Registry Software Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Standalone Cancer Registry Software Market Share by Players (2017-2022)
Table 10. Global Top Standalone Cancer Registry Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Standalone Cancer Registry Software as of 2021)
Table 11. Ranking of Global Top Standalone Cancer Registry Software Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Standalone Cancer Registry Software Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Standalone Cancer Registry Software Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Standalone Cancer Registry Software Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Standalone Cancer Registry Software Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Standalone Cancer Registry Software Revenue Market Share by Type (2017-2022)
Table 19. Global Standalone Cancer Registry Software Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Standalone Cancer Registry Software Revenue Market Share by Type (2023-2028)
Table 21. Global Standalone Cancer Registry Software Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Standalone Cancer Registry Software Revenue Market Share by Application (2017-2022)
Table 23. Global Standalone Cancer Registry Software Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Standalone Cancer Registry Software Revenue Market Share by Application (2023-2028)
Table 25. North America Standalone Cancer Registry Software Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Standalone Cancer Registry Software Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Standalone Cancer Registry Software Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Standalone Cancer Registry Software Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Standalone Cancer Registry Software Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Standalone Cancer Registry Software Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Standalone Cancer Registry Software Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Standalone Cancer Registry Software Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Standalone Cancer Registry Software Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Standalone Cancer Registry Software Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Standalone Cancer Registry Software Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Standalone Cancer Registry Software Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Standalone Cancer Registry Software Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Standalone Cancer Registry Software Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Standalone Cancer Registry Software Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Standalone Cancer Registry Software Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Standalone Cancer Registry Software Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Standalone Cancer Registry Software Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Standalone Cancer Registry Software Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Standalone Cancer Registry Software Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Standalone Cancer Registry Software Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Standalone Cancer Registry Software Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Standalone Cancer Registry Software Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Standalone Cancer Registry Software Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Standalone Cancer Registry Software Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Standalone Cancer Registry Software Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Standalone Cancer Registry Software Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Standalone Cancer Registry Software Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Standalone Cancer Registry Software Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Standalone Cancer Registry Software Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Standalone Cancer Registry Software Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Standalone Cancer Registry Software Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Standalone Cancer Registry Software Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Standalone Cancer Registry Software Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Standalone Cancer Registry Software Revenue by Country (2023-2028) & (US$ Million)
Table 60. McKesson Corporation Company Details
Table 61. McKesson Corporation Business Overview
Table 62. McKesson Corporation Standalone Cancer Registry Software Product and Services
Table 63. McKesson Corporation Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022) & (US$ Million)
Table 64. McKesson Corporation Standalone Cancer Registry Software SWOT Analysis
Table 65. McKesson Corporation Recent Developments
Table 66. Elekta Company Details
Table 67. Elekta Business Overview
Table 68. Elekta Standalone Cancer Registry Software Product and Services
Table 69. Elekta Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022) & (US$ Million)
Table 70. Elekta Standalone Cancer Registry Software SWOT Analysis
Table 71. Elekta Recent Developments
Table 72. C/NET Solutions Company Details
Table 73. C/NET Solutions Business Overview
Table 74. C/NET Solutions Standalone Cancer Registry Software Product and Services
Table 75. C/NET Solutions Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022) & (US$ Million)
Table 76. C/NET Solutions Standalone Cancer Registry Software SWOT Analysis
Table 77. C/NET Solutions Recent Developments
Table 78. Electronic Registry Systems Company Details
Table 79. Electronic Registry Systems Business Overview
Table 80. Electronic Registry Systems Standalone Cancer Registry Software Product and Services
Table 81. Electronic Registry Systems Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022) & (US$ Million)
Table 82. Electronic Registry Systems Standalone Cancer Registry Software SWOT Analysis
Table 83. Electronic Registry Systems Recent Developments
Table 84. Rocky Mountain Cancer Data Systems Company Details
Table 85. Rocky Mountain Cancer Data Systems Business Overview
Table 86. Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Product and Services
Table 87. Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022) & (US$ Million)
Table 88. Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software SWOT Analysis
Table 89. Rocky Mountain Cancer Data Systems Recent Developments
Table 90. Onco Company Details
Table 91. Onco Business Overview
Table 92. Onco Standalone Cancer Registry Software Product and Services
Table 93. Onco Standalone Cancer Registry Software Revenue in Standalone Cancer Registry Software Business (2017-2022) & (US$ Million)
Table 94. Onco Standalone Cancer Registry Software SWOT Analysis
Table 95. Onco Recent Developments
Table 96. Standalone Cancer Registry Software Market Trends
Table 97. Standalone Cancer Registry Software Market Drivers
Table 98. Standalone Cancer Registry Software Market Challenges
Table 99. Standalone Cancer Registry Software Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Standalone Cancer Registry Software Sales Market Share by Type: 2021 VS 2028
Figure 2. Public Database Features
Figure 3. Commercial Database Features
Figure 4. Global Standalone Cancer Registry Software Sales Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Healthcare Providers Case Studies
Figure 7. Research Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Standalone Cancer Registry Software Report Years Considered
Figure 10. Global Standalone Cancer Registry Software Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Standalone Cancer Registry Software Market Size 2017-2028 (US$ Million)
Figure 12. Global Standalone Cancer Registry Software Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Standalone Cancer Registry Software Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Standalone Cancer Registry Software Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Standalone Cancer Registry Software Market Share by Players in 2021
Figure 16. Global Top Standalone Cancer Registry Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Standalone Cancer Registry Software as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Standalone Cancer Registry Software Revenue in 2021
Figure 18. North America Standalone Cancer Registry Software Revenue Market Share by Company in 2021
Figure 19. North America Standalone Cancer Registry Software Revenue Market Share by Type (2017-2028)
Figure 20. North America Standalone Cancer Registry Software Revenue Market Share by Application (2017-2028)
Figure 21. North America Standalone Cancer Registry Software Revenue Share by Country (2017-2028)
Figure 22. United States Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Standalone Cancer Registry Software Revenue Market Share by Company in 2021
Figure 25. Europe Standalone Cancer Registry Software Revenue Market Share by Type (2017-2028)
Figure 26. Europe Standalone Cancer Registry Software Revenue Market Share by Application (2017-2028)
Figure 27. Europe Standalone Cancer Registry Software Revenue Share by Country (2017-2028)
Figure 28. Germany Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 29. France Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Standalone Cancer Registry Software Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Standalone Cancer Registry Software Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Standalone Cancer Registry Software Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Standalone Cancer Registry Software Revenue Share by Region (2017-2028)
Figure 37. China Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 40. India Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 42. China Taiwan Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 46. Latin America Standalone Cancer Registry Software Revenue Market Share by Company in 2021
Figure 47. Latin America Standalone Cancer Registry Software Revenue Market Share by Type (2017-2028)
Figure 48. Latin America Standalone Cancer Registry Software Revenue Market Share by Application (2017-2028)
Figure 49. Latin America Standalone Cancer Registry Software Revenue Share by Country (2017-2028)
Figure 50. Mexico Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 51. Brazil Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 52. Argentina Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Standalone Cancer Registry Software Revenue Market Share by Company in 2021
Figure 54. Middle East and Africa Standalone Cancer Registry Software Revenue Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Standalone Cancer Registry Software Revenue Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Standalone Cancer Registry Software Revenue Share by Country (2017-2028)
Figure 57. Turkey Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 59. UAE Standalone Cancer Registry Software Revenue (2017-2028) & (US$ Million)
Figure 60. McKesson Corporation Revenue Growth Rate in Standalone Cancer Registry Software Business (2017-2022)
Figure 61. Elekta Revenue Growth Rate in Standalone Cancer Registry Software Business (2017-2022)
Figure 62. C/NET Solutions Revenue Growth Rate in Standalone Cancer Registry Software Business (2017-2022)
Figure 63. Electronic Registry Systems Revenue Growth Rate in Standalone Cancer Registry Software Business (2017-2022)
Figure 64. Rocky Mountain Cancer Data Systems Revenue Growth Rate in Standalone Cancer Registry Software Business (2017-2022)
Figure 65. Onco Revenue Growth Rate in Standalone Cancer Registry Software Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed